The journey from melanocytes to melanoma
PP Centeno, V Pavet, R Marais - Nature Reviews Cancer, 2023 - nature.com
Over the past decade, melanoma has led the field in new cancer treatments, with impressive
gains in on-treatment survival but more modest improvements in overall survival. Melanoma …
gains in on-treatment survival but more modest improvements in overall survival. Melanoma …
A review of circulating tumour cell enrichment technologies
AJ Rushton, G Nteliopoulos, JA Shaw, RC Coombes - Cancers, 2021 - mdpi.com
Simple Summary Circulating tumour cells (CTCs) are cancer cells shed into the bloodstream
from tumours and their analysis can provide important insights into cancer detection and …
from tumours and their analysis can provide important insights into cancer detection and …
Advances in droplet digital polymerase chain reaction on microfluidic chips
D Xu, W Zhang, H Li, N Li, JM Lin - Lab on a Chip, 2023 - pubs.rsc.org
The PCR technique has been known to the general public since the pandemic outbreak of
COVID-19. This technique has progressed through three stages: from simple PCR to real …
COVID-19. This technique has progressed through three stages: from simple PCR to real …
Current and emerging applications of droplet digital PCR in oncology: an updated review
S Olmedillas-López, R Olivera-Salazar… - Molecular Diagnosis & …, 2022 - Springer
In the era of personalized medicine and targeted therapies for the management of patients
with cancer, ultrasensitive detection methods for tumor genoty**, such as next-generation …
with cancer, ultrasensitive detection methods for tumor genoty**, such as next-generation …
Recent advances in methods for circulating tumor cell detection
M Vidlarova, A Rehulkova, P Stejskal… - International Journal of …, 2023 - mdpi.com
Circulating tumor cells (CTCs) are released from primary tumors and transported through the
body via blood or lymphatic vessels before settling to form micrometastases under suitable …
body via blood or lymphatic vessels before settling to form micrometastases under suitable …
Future perspectives of uveal melanoma blood based biomarkers
Uveal melanoma (UM) is the most common primary intraocular malignancy affecting adults.
Despite successful local treatment of the primary tumour, metastatic disease develops in up …
Despite successful local treatment of the primary tumour, metastatic disease develops in up …
Circulating tumor cells (CTCs): a unique model of cancer metastases and non-invasive biomarkers of therapeutic response
Late-stage cancer metastasis remains incurable in the clinic and is the major cause death in
patients. Circulating tumor cells (CTCs) are thought to be metastatic precursors shed from …
patients. Circulating tumor cells (CTCs) are thought to be metastatic precursors shed from …
MagPure chip: an immunomagnetic-based microfluidic device for high purification of circulating tumor cells from liquid biopsies
The isolation of circulating tumor cells (CTCs) directly from blood, as a liquid biopsy, could
lead to a paradigm shift in cancer clinical care by providing an earlier diagnosis, a more …
lead to a paradigm shift in cancer clinical care by providing an earlier diagnosis, a more …
Liquid biopsy in melanoma: significance in diagnostics, prediction and treatment monitoring
Liquid biopsy is a common term referring to circulating tumor cells and other biomarkers,
such as circulating tumor DNA (ctDNA) or extracellular vesicles. Liquid biopsy presents a …
such as circulating tumor DNA (ctDNA) or extracellular vesicles. Liquid biopsy presents a …
[HTML][HTML] Emerging role of circulating tumor cells in immunotherapy
A Rzhevskiy, A Kapitannikova, P Malinina… - Theranostics, 2021 - ncbi.nlm.nih.gov
Over the last few years, immunotherapy, in particular, immune checkpoint inhibitor therapy,
has revolutionized the treatment of several types of cancer. At the same time, the uptake in …
has revolutionized the treatment of several types of cancer. At the same time, the uptake in …